Semisynthetic camptothecin which inhibits DNA topoisomerase I. Prepn: T. Miyasaka et al., JP Kokai 59 51289 (1984 to Yakult Honsha); M. C. Wani et al., J. Med. Chem. 29, 2358 (1986); and activity: S. Sawada et al., Chem. Pharm. Bull. 39, 3183 (1991). Synthesis: W. Cabri et al., Tetrahedron Lett. 36, 9197 (1995). HPLC determn in plasma: W. J. Loos et al., J. Chromatogr. B 694, 435 (1997). Structure/activity study: M.-L. Li et al., Clin. Cancer Res. 7, 168 (2001). Clinical pharmacodynamics and pharmacokinetics: C. H. Takimoto et al., J. Clin. Oncol. 15, 1492 (1997). Clinical evaluation in colorectal cancer: H. C. Pitot et al., Cancer 89, 1699 (2000). Review of clinical developments: C. H. Takimoto, R. Thomas, Ann. N.Y. Acad. Sci. 922, 224-236 (2000).
Antineoplastic.
Antineoplastic; Alkaloids/Natural Products; Camptothecin Derivatives; Topoisomerase I Inhibitor